[{"Assets_0_FY_USD":1954268000.0,"CommonStockSharesOutstanding_0_FY_shares":131161404.0,"EarningsPerShareBasic_4_FY_USD":4.07,"EarningsPerShareDiluted_4_FY_USD":3.96,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":-47589000.0,"NetIncomeLoss_4_FY_USD":528584000.0,"ProfitLoss_4_FY_USD":528584000.0,"Revenues_4_FY_USD":1095415000.0,"StockholdersEquity_0_FY_USD":1431849000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":133437126.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":129884967.0,"Ticker":"VIR","CIK":"1706431","name":"VIR BIOTECHNOLOGY, INC.","OfficialName":"Vir Biotechnology Inc. Common Stock","form":"10-K","period":"20211231","fy":"2021.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"3076942595.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20220228"}]